Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Granulocytic Leukemia, Chronic

resveratrol has been researched along with Granulocytic Leukemia, Chronic in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's12 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fabianowska-Majewska, K; Kaufman-Szymczyk, A; Lubecka, K; Majda, K; Szuławska-Mroczek, A1
Bai, X; Li, Q; Li, X; Ma, L; Sui, T; Zhang, L; Zhao, M1
Altman, JK; Beauchamp, E; Eklund, EA; Goussetis, DJ; Kosciuczuk, EM; Platanias, LC; Wu, EJ1
Dong, YQ; Duan, LN; Lu, CR; Luo, Y; Niu, TH; Wu, XP; Xiong, M; Xu, CS1
Li, YH; Wang, XJ1
Banerjee Mustafi, S; Chakraborty, PK; Raha, S1
Auberger, P; Cassuto, JP; Fenouille, N; Luciano, F; Puissant, A; Raynaud, S; Robert, G1
Ciarcia, R; d'Angelo, D; Damiano, S; Fiorito, F; Florio, S; Galdiero, M; Giordano, A; Lucchetti, C; Mattioli, E; Pacilio, C; Pagnini, D1
Auberger, P; Puissant, A1
Baran, Y; Kartal, M; Sahin, F; Saydam, G1
Chao, KS; Chen, YJ; Hou, MH; Jhih Cai, C; Liao, HF; Su, YC; Zheng, ZY1
Baran, Y; Cakir, Z; Can, G; Gunduz, U; Kartal, M1
Auberger, P; Belhacene, N; Cassuto, JP; Colosetti, P; Grosso, S; Jacquel, A; Puissant, A1
Chakraborty, PK; Chatterjee, M; Ganguly, S; Mustafi, SB; Raha, S1

Other Studies

14 other study(ies) available for resveratrol and Granulocytic Leukemia, Chronic

ArticleYear
Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis.
    Molecular medicine reports, 2019, Volume: 20, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Cell Line, Tumor; Clofarabine; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Resveratrol; Tretinoin

2019
Resveratrol inhibits STAT5 activation through the induction of SHP-1 and SHP-2 tyrosine phosphatases in chronic myelogenous leukemia cells.
    Anti-cancer drugs, 2018, Volume: 29, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Culture Techniques; Dose-Response Relationship, Drug; Enzyme Induction; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Resveratrol; Signal Transduction; STAT5 Transcription Factor; Tumor Suppressor Proteins

2018
Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.
    Cancer biology & therapy, 2014, Volume: 15, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Drug Synergism; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Oxides; Resveratrol; Stilbenes

2014
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation.
    Acta pharmacologica Sinica, 2015, Volume: 36, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Histones; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Transfection

2015
Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate.
    Genetics and molecular research : GMR, 2015, Jun-11, Volume: 14, Issue:2

    Topics: Apoptosis; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Resveratrol; Stilbenes

2015
Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70.
    PloS one, 2010, Jan-14, Volume: 5, Issue:1

    Topics: Blotting, Western; Cell Line, Tumor; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; HSP70 Heat-Shock Proteins; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microscopy, Fluorescence; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes

2010
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
    Cancer research, 2010, Feb-01, Volume: 70, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Chloromethyl Ketones; AMP-Activated Protein Kinases; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Benzamides; Blotting, Western; Caspase Inhibitors; Caspases; Cell Survival; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrolides; Microscopy, Confocal; Microscopy, Electron; Piperazines; Pyrimidines; Resveratrol; RNA Interference; Sequestosome-1 Protein; Stilbenes; Tumor Cells, Cultured; Vacuolar Proton-Translocating ATPases

2010
Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells.
    Journal of cellular physiology, 2010, Volume: 224, Issue:2

    Topics: Adenosine Triphosphate; Adult; Calcium; Female; Homeostasis; Humans; Intracellular Space; Ionomycin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Resveratrol; Stilbenes; Superoxide Dismutase

2010
AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia.
    Autophagy, 2010, Volume: 6, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Resveratrol; Stilbenes

2010
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
    Nutrition and cancer, 2011, Volume: 63, Issue:4

    Topics: Apoptosis; Ceramides; Down-Regulation; Glucosylceramides; Glucosyltransferases; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophospholipids; Morpholines; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; RNA, Neoplasm; Sphingosine; Stilbenes; Up-Regulation

2011
Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Cell Survival; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hedgehog Proteins; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Resveratrol; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stilbenes; Up-Regulation

2012
Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells.
    Anticancer research, 2012, Volume: 32, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Caspase 7; Cell Growth Processes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Piperazines; Pyrimidines; Resveratrol; Stilbenes

2012
Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Resveratrol; Stilbenes

2008
Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
    Cancer science, 2008, Volume: 99, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Blotting, Western; Caspase 3; Cell Nucleus; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; K562 Cells; Lactams, Macrocyclic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Promoter Regions, Genetic; Resting Phase, Cell Cycle; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Stilbenes; Transcription Factors

2008